Postdoctoral Fellowship for Drug Efficacy Models - Sao Paulo, Brasil - Drugs for Neglected Diseases Initiative

Drugs for Neglected Diseases Initiative
Drugs for Neglected Diseases Initiative
Empresa verificada
Sao Paulo, Brasil

há 3 semanas

Ana Silva

Postado por:

Ana Silva

beBee Recruiter


Descrição

DNDi partner institution / Instituição parceira da DNDi:

We are seeking a highly motivated individual for a translational research postdoctoral project in drug discovery for Chagas disease, a neglected tropical disease endemic to the Americas and for which there are no satisfactory drug treatment or vaccine options.

The selected researcher will develop the project at the School of Pharmaceutical Sciences of the University of São Paulo (FCF/USP) in the group of Prof.

Carolina Borsoi Moraes, as part of the Embrapii Unit Center for Innovation on Pharmaceuticals (CEINFAR-USP).

The University of São Paulo is a leading research and teaching institution in Latin America and the School of Pharmaceutical Sciences has a world-class team of professors and researchers working on the basic and applied research in human health.


Key project tasks:


  • Conduct _in vivo_ drug efficacy studies using the bioluminescence imaging in mouse models for Chagas disease.
  • Conduct _Trypanosoma cruzi _and mammalian cell lines culture in a biosafety level 2 laboratory, as well as High Content Screening assays, to support project goals.
  • Plan and execute experiments, data analysis, reporting and presentation.
  • Assist in project management and supervision of junior personnel.
  • PhD in biomedical, pharmaceutical, veterinary or related sciences.
  • Experience in animal models and laboratory animal handling.
  • Fluency in English.
  • Excellent oral and written communication skills.
  • Flexibility and adaptability to work within a multidisciplinary team and meet project's demands and goals.
  • Outstanding organizational competencies and meticulous recordkeeping abilities.
  • Prior experience in parasitology, infectious diseases animal models, and/or in vivo bioluminescence imaging is advantageous.

Mais empregos da Drugs for Neglected Diseases Initiative